Search

Author/Creator Lo, Y.

8. Discovery of INCB123667, a potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor for the treatment of cyclin E dysregulated cancers. (October 2022)

Authors:
Wee, S.; Ye, M.; Lo, Y.; Hansbury, M.; Shin, N.; Weber, M.; Roman, V.; Huo, L.; Skaggs, H.; Drake, K.; Kapilashrami, K.; Stump, K.; Yang, J.; Chand, S.; Timmers, C.; Hummel, J.; Ye, Y.; Zhang, G.; Yang, Y.O.; Covington, M.
Journal:
European journal of cancer
Issue:
Volume 174(2022)Supplement 1
Page Start:
S79
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Downmodulation of key inflammatory cell markers with a topical Janus kinase 1/2 inhibitor. (14th October 2015)

Authors:
Punwani, N.; Burn, T.; Scherle, P.; Flores, R.; Shi, J.; Collier, P.; Hertel, D.; Haley, P.; Lo, Y.; Waeltz, P.; Rodgers, J.; Shepard, S.; Vaddi, K.; Yeleswaram, S.; Levy, R.; Williams, W.; Gottlieb, A.B.
Journal:
British journal of dermatology
Issue:
Volume 173:Number 4(2015:Oct.)
Page Start:
989
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Downmodulation of key inflammatory cell markers with a topical Janus kinase 1/2 inhibitor. (1st October 2015)

Authors:
Punwani, N.; Burn, T.; Scherle, P.; Flores, R.; Shi, J.; Collier, P.; Hertel, D.; Haley, P.; Lo, Y.; Waeltz, P.; Rodgers, J.; Shepard, S.; Vaddi, K.; Yeleswaram, S.; Levy, R.; Williams, W.; Gottlieb, A.B.
Journal:
British journal of dermatology
Issue:
Volume 173:Number 4(2015:Oct.)
Page Start:
989
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗